Eli Lilly: Tirzepatide Shows Promise In Treating Obstructive Sleep Apnea In Two Phase 3 Clinical Trials
Tirzepatide led to a 63% mean reduction in restricted/obstructed breathing events per hour in patients with moderate to severe obstructive...
Pharma
AbbVie: Rinvoq, a monoclonal antibody against JAK enzyme, has superior efficacy in patients with atopic dermatitis compared to Dupixent
20% of patients treated with Rinvoq achieved 90% or greater reduction on the Eczema Area and Severity Index (EASI) and...
Lumicell: Injectable imaging agent illuminates residual breast cancer tissue during surgery to ensure tumor removal.
In the intervention group of 357 patients, 27 had additional removal of residual tumor based on imaging agent-guided technology. Six...
Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa
Gene therapy demonstrated clinically meaningful vision improvement in legally blind individuals. The therapy is capable of restoring vision even in...
Valneva Gears Up To Launch The First Ever Chikungunya Virus Vaccine
Ixchiq is a single shot live attenuated vaccine for the prevention of chikungunya virus vaccine which provided immunity to over...
Humanetics Corporation: BIO 300 Synthetic Genistein Nanosuspension May Protect Against Negative Effects Of Radiation Therapy In Lung Cancer Patients
BIO 300 use led to reduced levels of a proinflammatory/profibrotic cytokine associated with lung injury from radiation therapy. BIO 300...